Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Cipla
Daiichi Sankyo
McKinsey
Mallinckrodt
Farmers Insurance
Colorcon
Dow

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LOPERAMIDE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Loperamide Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00003057 Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed Cancer and Leukemia Group B Phase 3 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057 Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed National Cancer Institute (NCI) Phase 3 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057 Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed Southwest Oncology Group Phase 3 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057 Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed Eastern Cooperative Oncology Group Phase 3 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Loperamide Hydrochloride

Condition Name

Condition Name for Loperamide Hydrochloride
Intervention Trials
Diarrhea 10
Fecal Incontinence 7
Cancer 3
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Loperamide Hydrochloride
Intervention Trials
Diarrhea 21
Fecal Incontinence 7
Breast Neoplasms 7
Irritable Bowel Syndrome 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Loperamide Hydrochloride

Trials by Country

Trials by Country for Loperamide Hydrochloride
Location Trials
United States 119
Mexico 7
Canada 6
Germany 3
United Kingdom 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Loperamide Hydrochloride
Location Trials
California 10
Florida 10
Texas 8
North Carolina 7
New York 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Loperamide Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Loperamide Hydrochloride
Clinical Trial Phase Trials
Phase 4 10
Phase 3 10
Phase 2/Phase 3 4
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Loperamide Hydrochloride
Clinical Trial Phase Trials
Completed 25
Recruiting 12
Not yet recruiting 6
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Loperamide Hydrochloride

Sponsor Name

Sponsor Name for Loperamide Hydrochloride
Sponsor Trials
Puma Biotechnology, Inc. 3
Uniformed Services University of the Health Sciences 2
Ministry of Defence, United Kingdom 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Loperamide Hydrochloride
Sponsor Trials
Other 76
Industry 30
U.S. Fed 8
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Fuji
Express Scripts
Queensland Health
Johnson and Johnson
McKesson
Chinese Patent Office
Merck
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.